Geron Corp (NAS:GERN)
$ 4.17 0.11 (2.71%) Market Cap: 2.52 Bil Enterprise Value: 2.27 Bil PE Ratio: 0 PB Ratio: 8.60 GF Score: 35/100

Q3 2022 Geron Corp Earnings Call Transcript

Nov 03, 2022 / 01:00PM GMT
Release Date Price: $2.03 (-5.58%)
Aron Feingold
Geron Corporation - VP of IR & Corporate Communications

Good morning, everyone. Welcome to the Geron Corporation Third Quarter 2022 Conference call. I am Aron Feingold, Geron's Vice President of Investor Relations and Corporate Communications. I'm joined today by the following members of Geron's management team, Dr. John Scarlett, Chairman and Chief Executive Officer; Olivia Bloom, Executive Vice President of Finance and Chief Financial Officer and Treasurer.; Dr. Faye Feller, Executive Vice President and Chief Medical Officer; and Anil Kapur, Executive Vice President of Corporate Strategy and Chief Commercial Officer.

Before we begin, please note that during the course of this presentation and question-and-answer session, we will be making forward-looking statements regarding future events, performance, plans, expectations and other projections, including those related to the therapeutic potential and potential regulatory approval of imetelstat, anticipated clinical and commercial events and related time lines, the sufficiency of Geron's financial resources and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot